Depression studies

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown

Showing 2,365-2,376 of 7,264

CompletedNCT02942017

Safety study of Safety and Efficacy of SAGE-547 in depression

Official study title

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Chandler

DepressionMedication studyAges 18–45

Countries: United States
Sponsor: Supernus Pharmaceuticals, Inc. (Pharmaceutical company)

View study

CompletedNCT02614547

SAGE-547 in people with Severe Postpartum Depression

What is this study about?

This study evaluated the safety and effectiveness of SAGE-547 for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Atlanta

DepressionMedication studyAges 18–45

Countries: United States
Sponsor: Supernus Pharmaceuticals, Inc. (Pharmaceutical company)

View study

CompletedNCT07047820

A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy

Official study title

Prospective, Observational Survey Study Assessing Effectiveness of Zuranolone in Improving PPD Symptoms in the Real-world Setting

This study has finished and is no longer accepting participants.

In Woonsocket

DepressionObservational studyAges 18+

Countries: United States
Sponsor: Biogen

View study

CompletedNCT06117397

A Text Messaging Intervention to Reduce Perinatal Depression Risk

This study has finished and is no longer accepting participants.

In Worcester

DepressionInterventional studyAges 16–45

Countries: United States
Sponsor: University of Massachusetts, Worcester

View study

CompletedNCT07329270

A Trauma-Informed Primary Health Care Intervention to Prevent Postpartum Depression After Disaster

Official study title

Postpartum Depression Prevention Program in Disaster-Affected Regions

This study has finished and is no longer accepting participants.

In Hatay

DepressionBehavioural studyAges 18+

Countries: Türkiye
Sponsor: Istanbul Bilgi University

View study

CompletedNCT06750640

Acupoint Thermal Radiation Characteristics in Adolescents with MDD

Official study title

Acupoint Thermal Radiation Characteristics in Adolescents with Major Depressive Disorder and Establishment of Diagnostic Model

This study has finished and is no longer accepting participants.

In Hangzhou

DepressionObservational studyAges 12–17

Countries: China
Sponsor: Xiaomei Shao

View study

CompletedNCT06372834

Adjuvant Accelerated piTBS for Reducing Suicide prevention in TRD Patients

Official study title

Efficacy of Adjuvant Accelerated Prolonged Intermittent Theta Burst Stimulation for Reducing Suicidal Ideation in Therapy-resistant Depressed Patients: A Randomized, Sham-controlled Trial

This study has finished and is no longer accepting participants.

In Taipei

Depression, SuicidalityDevice studyAges 20–65

Countries: Taiwan
Sponsor: Tri-Service General Hospital (TSGH)

View study

WithdrawnNCT03060967

Assessment of Hedonic and Motivational States in Major Depression ( MOODDIS)

Official study title

Use of an Innovative and Easy-to-use Tool Based on the Perception of Visual Food Stimuli for Assessing Hedonic and Motivational States in Major Depression.

This study was withdrawn before enrollment.

In Bordeaux

DepressionBehavioural studyAges 18–60

Countries: France
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

View study

CompletedNCT07413705

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

Official study title

Safety and Efficacy of the Combined BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

This study has finished and is no longer accepting participants.

Multiple locations, including Winter Garden

DepressionDevice studyAges 40+

Countries: United States, Canada
Sponsor: BTL Industries Ltd.

View study

CompletedNCT07413692

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women

Official study title

Safety and Efficacy of the Combined BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence Among Postpartum Women and Women up to Five Years After Childbirth

This study has finished and is no longer accepting participants.

Multiple locations, including Garfield Heights

DepressionDevice studyAges 22–60

Countries: United States
Sponsor: BTL Industries Ltd.

View study

CompletedNCT05041647

Cannabinoids as a Treatment for Insomnia in Major Depression

Official study title

A Pilot, Double-Blind, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of a Cannabis-Infused Oil For Treatment of Insomnia in Major Depression

This study has finished and is no longer accepting participants.

In Hamilton

DepressionMedication studyAges 19+

Countries: Canada
Sponsor: St. Joseph's Healthcare Hamilton

View study

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.